Submit Deal

ZOBIO

HQ - Leiden

Summary

ZoBio specializes in fragment-based drug discovery and offers integrated gene-to-lead programs or individual components tailored to their clients' needs.

Deals Overview

Total Deals1

Valued Deals0

Total Value-

Avg. Deal Size-

Market Context

Senior Management

Gregg Siegal
CEO
Jan Schultz
Executive
Rob Heetebrij
Executive

Sort

23 Jan 2024|Netherlands|Biotechnology

Target: ZOBIO

Bidder: ONCODESIGN SERVICES

2 Service Providers

1 Target | 1 Bidder

7 Dealmakers

3 Target | 4 Bidder

n/a

Value